AIMS AND OBJECTIVES: To examine how subgroups of patients with chronic obstructive pulmonary disease, identified by ratings of symptoms (dyspnoea, anxiety, depression and fatigue), affect healthcare use and mortality. BACKGROUND: People with chronic obstructive pulmonary disease often experience multiple symptoms. The importance of multiple symptoms and symptom clusters has received increased attention. However, little is known about symptom clusters and their effect on healthcare use and mortality in this population. DESIGN: Descriptive cross-sectional study. METHODS: This secondary data analysis used data from the National Emphysema Treatment Trial. Participants (n = 597) had severe chronic obstructive pulmonary disease. Descriptive and inferential statistics were used to analyse the data that were drawn from structured interviews, questionnaires and clinical measures. RESULTS: Three subgroup clusters emerged based on four symptom ratings. Mean age, proportion with higher education, proportion using oxygen, disease severity, exercise capacity and quality of life differed significantly between subgroups. Participants with high levels of symptoms used healthcare services more and were more likely to have died at the five-year follow-up than those with low levels of symptoms. Symptom cluster subgroups had more significant relationship with mortality than single symptoms. CONCLUSION: Patients with high levels of symptoms require greater clinical attention. RELEVANCE TO CLINICAL PRACTICE: Understanding subgroups of patients, based on symptom ratings and their adverse effect on outcomes, may enable healthcare providers to assess multiple symptoms and identify subgroups of patients at risk of increased healthcare use and mortality. Targeting modifiable symptoms within the cluster may be more beneficial than focusing on a single symptom for certain health-related outcome.
AIMS AND OBJECTIVES: To examine how subgroups of patients with chronic obstructive pulmonary disease, identified by ratings of symptoms (dyspnoea, anxiety, depression and fatigue), affect healthcare use and mortality. BACKGROUND:People with chronic obstructive pulmonary disease often experience multiple symptoms. The importance of multiple symptoms and symptom clusters has received increased attention. However, little is known about symptom clusters and their effect on healthcare use and mortality in this population. DESIGN: Descriptive cross-sectional study. METHODS: This secondary data analysis used data from the National Emphysema Treatment Trial. Participants (n = 597) had severe chronic obstructive pulmonary disease. Descriptive and inferential statistics were used to analyse the data that were drawn from structured interviews, questionnaires and clinical measures. RESULTS: Three subgroup clusters emerged based on four symptom ratings. Mean age, proportion with higher education, proportion using oxygen, disease severity, exercise capacity and quality of life differed significantly between subgroups. Participants with high levels of symptoms used healthcare services more and were more likely to have died at the five-year follow-up than those with low levels of symptoms. Symptom cluster subgroups had more significant relationship with mortality than single symptoms. CONCLUSION:Patients with high levels of symptoms require greater clinical attention. RELEVANCE TO CLINICAL PRACTICE: Understanding subgroups of patients, based on symptom ratings and their adverse effect on outcomes, may enable healthcare providers to assess multiple symptoms and identify subgroups of patients at risk of increased healthcare use and mortality. Targeting modifiable symptoms within the cluster may be more beneficial than focusing on a single symptom for certain health-related outcome.
Authors: Christine Miaskowski; Bruce A Cooper; Steven M Paul; Marylin Dodd; Kathryn Lee; Bradley E Aouizerat; Claudia West; Maria Cho; Alice Bank Journal: Oncol Nurs Forum Date: 2006-09-01 Impact factor: 2.172
Authors: Andrea L Cheville; Paul J Novotny; Jeffrey A Sloan; Jeffrey R Basford; Jason A Wampfler; Yolanda I Garces; Aminah Jatoi; Ping Yang Journal: J Pain Symptom Manage Date: 2011-03-12 Impact factor: 3.612
Authors: Vincent S Fan; Scott D Ramsey; Nicholas D Giardino; Barry J Make; Charles F Emery; Phillip T Diaz; Joshua O Benditt; Zab Mosenifar; Robert McKenna; Jeffrey L Curtis; Alfred P Fishman; Fernando J Martinez Journal: Arch Intern Med Date: 2007-11-26
Authors: Jacob N de Voogd; Johan B Wempe; Gerard H Koëter; Klaas Postema; Eric van Sonderen; Adelita V Ranchor; James C Coyne; Robbert Sanderman Journal: Chest Date: 2008-11-24 Impact factor: 9.410
Authors: Christine Miaskowski; Andrea Barsevick; Ann Berger; Rocco Casagrande; Patricia A Grady; Paul Jacobsen; Jean Kutner; Donald Patrick; Lani Zimmerman; Canhua Xiao; Martha Matocha; Sue Marden Journal: J Natl Cancer Inst Date: 2017-01-24 Impact factor: 13.506
Authors: Jungeun Lee; Huong Q Nguyen; Monica E Jarrett; Pamela H Mitchell; Kenneth C Pike; Vincent S Fan Journal: Heart Lung Date: 2018-02-01 Impact factor: 2.210
Authors: Nancy Fugate Woods; Lori A Cray; Ellen Sullivan Mitchell; Fred Farrin; Jerald Herting Journal: Biol Res Nurs Date: 2018-01-15 Impact factor: 2.522
Authors: Vivi L Christensen; Tone Rustøen; Bruce A Cooper; Christine Miaskowski; Anne H Henriksen; Signe B Bentsen; Are M Holm Journal: Int J Chron Obstruct Pulmon Dis Date: 2016-08-02
Authors: Huong Q Nguyen; Jerald R Herting; Kenneth C Pike; Sina A Gharib; Gustavo Matute-Bello; Soo Borson; Ruth Kohen; Sandra G Adams; Vincent S Fan Journal: BMC Pulm Med Date: 2016-12-03 Impact factor: 3.317